Topic Archives: Marc Lichtenfeld

There was a new teaser email from the Oxford Income Letter folks this morning that caught my eye… and in these tumultuous days, when I don’t really feel like doing any trading around these short-term gyrations caused by pandemic panic and political pandering, I confess to being extra-interested in relatively stable dividend-paying investments. So let’s […]

Turn down the football game and bring out the pies, it’s that time again! Stock Gumshoe is mostly closed down for the holiday week, but we do have to continue our annual tradition of calling out our “Turkey of the Year” … so take a pause from arguing with your family and join us, won’t […]

I don’t have any big updates on the Real Money Portfolio this week, or on my big-picture thinking (still holding a lot more cash than usual, still being mindful of stop loss triggers for momentum/growth stocks, still hoping some of my favorites will reach prices that inspire a buy soon, since we’re right in the […]

The beginning of the latest ad from Marc Lichtenfeld’s Lightning Trend Trader is good and juicy, at the very least… how could you not open up the ad and pay attention? “The KILLER Hiding in Your Medicine Cabinet “These Common Drugs Take a Life Every 12 Minutes (Who’s at Risk?) “Here’s the NEW Breakthrough and […]

Fear Of Missing Out is such a big deal that it gets its own acronym in my book (FOMO — and a clever FOMO-fueling website here), and it drives investors to take huge chances just so they don’t have to worry about missing a chance at stupendous gains. That’s what many newsletter ads use to […]

This article originally ran on January 12… the teaser pitch was still being circulated heavily last week, and the stock released earnings on February 3 that disappointed investors, bringing shares down about 15% (it was teased as a “$7 biotech,” and briefly $8, before then). The original Jan. 14 “special event” catalyst teased by Lichtenfeld, […]

Every biotech-related teaser ad promises that you can make life-changing profits while also curing the world of a dread disease, of course — that’s why we love ’em. But this one’s a little bit different — they are teasing a biotech company that is trying to develop new drugs, but according to the pitch this […]

Healthcare-focused newsletter, recommended stocks primarily of emerging device and biotech companies. Was helmed by Marc Lichtenfeld, who moved on to other publications, but stopped publishing after a short while — Lightning Trend Trader, a current publication of Lichtenfeld’s with The Oxford Club, sometimes covers biotech stocks.

Comments

  • WPG was $6, now $1, no dividend Can you get 100% yield on your savings Marc Lichtenfeld? No you cannot....

  • Covered that one here: https://www.stockgumshoe.com/reviews/oxford-income-letter-the/oxford-incomes-great-2020-real-esta...

  • Alexander Green recommended 07/15/2020 AGNC @$13.50 and it's still a BUY Marc Lichtenfeld just sent this link https:...

  • I just looked at all the portfolios and STAG is nowhere Marc Lichtenfeld in Compound Income Portfoliorecommended DLR 01...

  • could you elaborate on the energy company highlighted by Marc Lichtenfeld using "Infinite Energy," converting trash into...

  • If you had a trading system that generated those kind of returns would you sell it for $1500 ? Of course you would becau...

  • Travis, due to my internet provider, I get your Gumshoe document 1-day late. Hopefully you are still reading replies or ...

  • has anyone subscribed to the Extreme Dividends letter? results?...

  • The two pitches we've looked at from Marc this year are about a fintech stock, ...

  • Marc Lichtenfeld doesn't care if he's right or wrong. Every loss I have is from his recommendations from the Oxford Club...

  • Has anyone had legit success with the lightning trade report?...

  • As far as me is concerned, any thing smelling at Oxford Club, I say NO THANKS, allthough Marc Lichtenfeld isn´t as bad ...

  • Haven't written about Lichtenfeld's tease, but someone sent it to me today and it's clearly Ligand being touted as this ...

  • Unlike some other facets of the Oxford Club, the Income Letter, which focuses on dividend stocks, is a no nonsense knowl...

  • This is almost the same ad Marc Lichtenfeld from Oxford used in around 2012? to push Graftech (GTI). The same company Mi...

  • I would say Marc Lichtenfeld offered the 300,000% as a long term (retire on) potential if it was applied to all genetic...

  • This stock tease is back from Alexander Green and Oxford. Months Later. What is the deal, Travis? p.s. is the Marc...

  • I recently saw Marc Lichtenfeld at a Moneyshow where he was talking about high yield stocks in a low yield environment. ...

  • I just received a teaser from Marc Lichtenfeld (oxford communications / lightning trader for a stock that is not public ...

  • What do you think the Marc Lichtenfeld "How to play the first 100 day window" Trump Ten Trades may be?...

  • I think that's probably the Marc Lichtenfeld promo I wrote about last month -- you can see the article here: http://www....

  • Gummies, Last week I gave you part 1 of "Why the Bull Market in Biotech Will Continue (Part 1 of 2) here... http://w...

  • $PDLI: For those who would happened to be in PDLI, Marc Lichtenfeld, Chief Income Strategist, at The Oxford Club has a n...

  • This from Marc Lichtenfeld at the Oxford Club: I will post part 2 once I get it. Not a compelling read but it is reassu...

  • Thomas: Found your comments interesting and informative - if only Oxford Club advertised its premium services something...

  • Greta: I'm not sure I see what the point is in trying to guess the 4 "great opportunities" being hyped by Marc Lichtenf...

  • Alison: Marc Lichtenfeld is talking about his results during the year 2013 - his "service" was actually called "Healthc...

  • My impression is that Marc Lichtenfeld (it's not Lichtenstein) of Oxford Club is a smart guy and works hard - but my adv...

  • Wow, First to comment! Too bad I don't have much to say about BDC's but I do like the back door way to potential IPO's ...

  • Marc Lichtenfeld is spouting off about a new top performing research service called Lightning Trends Trader. Anyone out...

  • I have never had First Access, but have been stung by Marc Lichtenfeld when he wrote about Accuray (ARAY) for Xcelerated...

  • Recently subscribed reader who is impressed and enjoys your site. Will probably become a paying subscriber very soon. ...

  • Thanks -- and good point on the "triple," though I think bypassing the fact that you need to put up collateral for a sho...

  • Thanks, Gumshoe. I got this teaser this week and it had me tempted, but I typed Marc Lichtenfeld into your search engin...

  • http://finance.yahoo.com/echarts?s=MELA#symbol=MELA;range=2y I'm just killing time between church & the BbQ at th...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info